Colorectal Surgical Procedures
Conditions
Brief summary
The purpose of this study is to prospectively generate device-specific clinical data related to the performance of Echelon Contour per its instructions for use (IFU).
Interventions
DEVICEEchelon Contour
There is no intervention, beyond necessary clinical care, in this study. Echelon Contour is used for transection and resection in colorectal surgical procedures per its instructions for use (IFU).
Sponsors
Ethicon Endo-Surgery
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Elective colorectal procedure where Echelon Contour is planned to be used for transection and resection of the colon * Willingness to give consent and comply with all study-related evaluations and visit schedule. If the participant is less than (\<) 18 years of age, the participant's parent/legal guardian must be willing to give permission for the participant to participate in the study and provide written Informed Consent for the participant. In addition, assent must be obtained from pediatric participants who possess the intellectual and emotional ability to comprehend the concepts involved in the study. If the pediatric participant is not able to provide assent (due to age, maturity and/or inability to intellectually and/or emotionally comprehend the study); the parent/legal guardian's written Informed Consent for the participant will be acceptable for the participant to be included in the study * Anatomical region must be of sufficient size for the device to be used
Exclusion criteria
Preoperative * Females who are pregnant * Physical or psychological condition which would impair study participation * Participant previously enrolled into the study (example: participant enrolled for Hartmann's procedure then cannot be reenrolled for the Hartmann's reversal) Intraoperative \- Study device use not attempted
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants with Echelon Contour Success | interoperative | Echelon Contour success based on surgeon responses on question 1 in the surgeon reported outcome measures (SROM) will be reported. Surgeon will be asked to choose option Yes or No for following question: Did Echelon Contour provide acceptable performance considering other therapeutic alternatives? |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants with Device-related Adverse Events (AEs) | 28 days post-procedure | An AE is defined as any untoward medical occurrence, regardless of its relationship to the study device or the study procedure. An untoward medical occurrence includes any new, undesirable medical experience or worsening of a pre-existing condition, which occurs throughout the duration of the clinical study. |
Countries
United States
Outcome results
None listed